BACKGROUND Several observational studies suggested that vitamin E intake is related to the risk of kidney cancer; however, the results of published studies are inconsistent. MATERIAL AND METHODS A meta-analysis was performed to assess the relationship between vitamin E intake and the risk of kidney cancer by searching PubMed and Medline through August 2015. We computed pooled relative risks (...

Kidney cancer is estimated to affect more than 54,000 individuals in the United States each year and to be responsible for 13,000 deaths in the United States annually. When a patient with localized kidney cancer is treated surgically, 5and 10-year disease-specific survival can approach 95%. However, despite the remarkable recent advances in targeted therapeutics for kidney cancer, this disease ...

Renal cancer accounts for 3% of malignant neoplasms in adults. In 2008, more than 54,000 cases of kidney cancer were diagnosed, and more than 13,000 deaths occurred in the United States. In 2006, the number of deaths from renal cancer was 26,400 in the European Union and more than 100,000 worldwide. The cost of care for kidney cancer in the United States alone was more than $4.4 billion in 2004...

• History and physical examination • Laboratory tests: CBC, LDH, metabolic panel (creatinine, electrolytes, AST, ALT, alkaline phosphatase, bilirubin, INR, PTT, calcium, magnesium, phosphate, albumin), urinalysis and urine cytology • Imaging • Primary tumour i. Abdominal/pelvic CT with and without intravenous contrast ii. Abdominal MRI if CT suggests caval thrombus or because of a contrast alle...

BACKGROUND The incidence of malignancies in kidney transplant recipients is increasing. Breast cancer is a common malignancy after kidney transplantation and can be more aggressive in kidney transplant recipients than in the general population. In this study, we evaluated the incidence and prognosis of breast cancer in kidney transplant recipients. FINDINGS Between 1993 and 2013, 750 kidney t...

The incidence of cancer is sharply increasing. Cancer is a leading cause of death as well as a significant burden on society. The incidence of urological cancer has shown a higher than average increase and will become an important concern in the future. Therefore, an overall and accurate understanding of the incidence of urological cancer is essential. In this study, which was based on the Kore...

Background and Objective: Increment in cancer prevalence and subsequent need for chemotherapy leads to distinct kidney-related diseases such as acute kidney injury (AKI). Cisplatin is a common chemotherapeutic agent that has been used in many cancers; however, it can damage renal cells. Capparis spinosa is an important therapeutic plant in Persian medicine that encompasses high amounts of bioac...

Sirolimus, an immunosuppressant option for kidney transplant recipients, may reduce cancer risk by interrupting the mammalian target of rapamycin pathway. However, studies of sirolimus and cancer incidence in kidney recipients have not been definitive, and have had limited ability to examine specific cancer types. The literature was systematically reviewed to identify randomized controlled tria...

The excess risk for cancer in kidney transplant recipients is substantial, but the allograft and patient survivals after cancer development are under-studied. This is a population-based cohort study of all primary live and deceased donor kidney transplant recipients in Australia and New Zealand between 1990-2012. The risks of overall graft loss and death with a functioning graft in kidney trans...